Mkt Cap $350M
52-Week Range
Bicycle Therapeutics plc (BCYC) reported collaboration revenue of $72.6 million for FY 2025, a 106% YoY increase from $35.3 million in 2024, driven by accelerated recognition from Novartis and Bayer collaborations following termination notices.
Revenue breakdown: Single Reportable Segment (100%).
$350M
Market Cap
$73M
Revenue
-$219M
Net Income
Revenue by Segment